Patent application no. 201880011863.5, entitled "Detection of a biomarker in a sample of a flowable substance" covers the entire POC system and the method of detecting a biomarker in e.g. blood. The patent provides protection until 2038. The notice of allowance means that the CNIPA will approve the company's patent application and issue the patent.

Including the new patent, Calmark owns 20 patents and 11 design protections for both the instrument and the test cassette on important markets.

"We continue the systematic patent work and focus on markets where the value of patent protection is the highest," says Camilla Arneving, acting CEO of Calmark. "China invests heavily in intangible assets and the number of patent applications increases year by year. Therefore, it is especially important that our application now is approved."

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.

‍